Objective To evaluate whether human epididymis protein 4 (HE 4) and CA 125 correlate
with known high‐risk prognostic factors for endometrial cancer. Design Prospective …

Aim An optimal surgical staging in the group of patients with the high‐risk type of
endometrial cancer is often limited by age and serious internal comorbidities. Therefore, in …

Objective The purpose of this study was to evaluate the performance of preoperative serum
levels of human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) in the …

Objective: To date, biomarkers are not routinely used in endometrial cancer diagnosis,
prognosis, and follow-up. The purpose of this study was to evaluate whether serum HE4 was …

Objectives To evaluate the diagnostic and prognostic potential of preoperative serum CA-
125 and HE4 levels in patients with endometrial cancer. Methods Prospective case–control …

This study aims to investigate the correlation between preoperative human epididymis
protein 4 (HE4) levels, endometrial cancer (EC) staging, and ideal cutoff for stage prediction …

Background: The purpose of this study was to assess the diagnostic and prognostic impact
of preoperative serum determination of human epididymis protein 4 (sHE4), and to …

There is no recognized serum biomarker to predict the recurrence of endometrial carcinoma
(EC). We aimed to explore serum human epididymis protein 4 (HE4) and cancer antigen …

OBJECTIVE: To evaluate the prognostic value of pretherapeutic serum HE4 in endometrial
cancer in comparison to CA125. METHODS: HE4 and CA125 serum levels were analyzed …

Endometrial cancer is the most common genital cancer in high‐resource countries.
Treatment is essentially surgical, but the role of lymphadenectomy in the treatment of low …